Industry News

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

RB’s OTC business rises by a third amid COVID-19
Premium

8 May 2020

Worldwide sales at RB’s OTC business shot up by a third on a like-for-like basis in the first quarter of 2020 as demand was boosted by the COVID-19 pandemic. RB said there had been “exceptional demand” for Mucinex in North America and for Nurofen in Europe, Australia and New Zealand.

Read the full story

GSK gets a lift from Pfizer and COVID-19
Premium

1 May 2020

Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 46% at constant exchange rates in the first quarter of 2020, following consolidation of Pfizer’s Consumer Healthcare products and the COVID-19 pandemic.

Read the full story